1 |
Lee YN. New Flora of Korea. Seoul: Kyo-Hak Publishing Co., Ltd.; 2006, p. 261.
|
2 |
Heo J. Dong-eui-bo-gam. Seoul: Bupin Publishing Co., Ltd.; 2007, p. 2010.
|
3 |
The Herbal medicine compilation committee of Oriental medicine college. Herbal medicine. Seoul: Younglim Publishing; 2006, p. 331-3.
|
4 |
Dae SM. Hang-am-joong-cho-yak. Taipei: Kyeup- seogook-youhan-gongsa; 1983, p. 222-4.
|
5 |
State Administration of Traditional Chinesemedicine. Joong-hwa-bon-cho. Shanghai: Sang-hae science technique Publishing; 2005, p. 605-10.
|
6 |
Choi OB. The importance of clinical mistletoe cancer therapy and koreanmistletoe pharmacopuncture preparation development and application possibility for oriental medicine. J ofKorean Pharmacopuncture Institute 2009;12(1):77-89.
|
7 |
Aoki H, Kakinuma K, Morita K, Kato M, Uzuka T, Igor G, et al. Therapeutic efficacy of targeting chemotherapy using local hyperthermia and thermosensitive liposome: evaluation of drug distribution in a rat glioma model. Int J Hyperthermia 2004;20(6):595-605.
DOI
ScienceOn
|
8 |
An YL, Nie F, Wang ZY, Zhang DS. Preparation and characterization of realgar nanoparticles and their inhibitory effect on rat glioma cells. Int J Nanomedicine 2011;6:3187-94.
|
9 |
Amberger VR, Hensel T, Ogata N, Schwab ME. Spreading and migration of human glioma and rat C6 cells on central nervous system myelin in vitro is correlated with tumor malignancy and involves a metalloproteolytic activity. Cancer Res 1998;58(1):149-58.
|
10 |
Bello L, Giussani C, Carrabba G, Pluderi M, Costa F, Bikfalvi A. Angiogenesis and invasion in gliomas. Cancer Treat Res 2004;117:263-84.
DOI
|
11 |
Yoo CH, Lee U, Kim YB, Kang DS, Park CW, Yoo YM. Effect of tamoxifen in C6 glioma cells. J Korean Neurosurg Soc 1997;26:5-10.
|
12 |
Yoon TJ, Yoo YC, Kang TB, Lee KH, Kwak JH, Baek YJ, et al. Fermented extracts of Korean mistletoe with lactobacillus(FKM-110) stimulate macrophage and inhibit tumor metastasis. Korean J of Food Science and Technology 1999;31(3):838-47.
|
13 |
Choi SH, Lyu SY, Park WB. Mistletoe lectin induces apoptosis and telomerase inhibition in human A253 cancer cells through dephosphorylation of Ark. Archives of Pharmacal Reasearch 2004;27(1):68-76.
DOI
|
14 |
Park WB, Lyu SY, Kim JH, Choi SH, Chung HK, Ahn SH, et al. Inhibition of tumor growth and metastasis by Korean mistletoe lectin is associated with apoptosis and antiangiogenesis. Cancer Biotherapy and Radiopharmaceuticals 2001;16:439-47.
DOI
ScienceOn
|
15 |
Rhew KY, Kim YC, Lee JH, Woo HJ. The Effects of Loranthus parasiticus Merr. on Cell Cycle and Expression of Related Genes in HepG2 Cell. Korean J Orient Int Med 2005;26(1):60-73.
|
16 |
Muntane J, la Mata MD. Nitric oxide and cancer. World J Hepatol 2010;2(9):337-44.
DOI
ScienceOn
|
17 |
Kim MJ, Lee MS, Kim JH. Effect of Korean mistletoe extract and lectin on the preneoplastic hepatic lesion and apoptosis in experimental hepatocarcinogenesis. J of Korean Society Food Science and Nutrition 2002;31(5):782-7.
DOI
|
18 |
Kim SU, Kim BR, Heo K, Lim SW. Comparative Study of KoreanMisltetoe Lectin and Bee Venom on the Anti-Cancer Effect and Its Mechanisms of Action in Hepatocellular Carcinoma Cells. Korean J Orient Int Med 2009;30(4):845-57.
|
19 |
Kim JK, Kim YC, Lee JH, Woo HJ. The Effects of Artermisiae Capillaris Herba, Curcumae Rhizoma, Loranthi Ramulus, and Orostachys Herba on Expression of Angiogenic Factors in HepG2 Cells. Korean J Orient Int Med 2007;28(1):149-65.
|
20 |
Yang EY, Yeo JH, Jin JY, Kim HS, Park WB, Suh JJ, et al. Anti-tumor effect of Korean mistletoe extract intensified with mistletoe lectin against melanoma cells in vitro and in vivo. Korean J of Pharmacognosy 2003;34(3):218-22.
|
21 |
Yoon TJ, Park SM, Yang SH, Jung HY, Lee AN, Yoo YC, et al. In Vivo toxicity and anti-tumor activity of Korean mistletoe extracts. Korean J of Pharmacognosy 2009;40(3):205-12.
|
22 |
Korea Food & Drug Administration. Korean Herbal medicine Standards exclusive of Pharmacopoeia. Seoul: Shinilbooks Publishing; 2007, p. 46.
|
23 |
Uisung-Dang editorial department. Shin-nong -bon-cho-kyeong. Seoul: Uisung-Dang Publishing; 2012, p. 210.
|
24 |
Lee CH, Kim JK, Kim HY, Park SM, Lee SM. Immunomodulating effects of Korean mistletoe lectin in vitro and in vivo. International Immunopharmacology 2009;9:1555-61.
DOI
ScienceOn
|
25 |
Kim BK, Choi MJ, Park KY, Cho EJ. Protective effects of Korean mistletoe lectin on radical-induced oxidative stress. Biological and Pharmaceutical Bulletin 2010;33(7):1152-8.
DOI
ScienceOn
|
26 |
Lee SJ, Lee MK, Choi GP, Kim NY, Roh SK, Heo MY, et al. Inhibitory effect of Korean mistletoes on the oxidative DNA damage. Korean J of Medicinal Crop Science 2003;11(2):89-96.
|
27 |
Ham SS, Kang ST, Choi KP, Park WB, Lee DS. Antimutagenic effect of Korean mistletoe extracts. J of Korean Society Food Science and Nutrition 1998;27(2):359-65.
|
28 |
Lee JH, Cho SO, Ban JY, Song KS, Seong YH. Neuroprotective effect of Korean mistletoe extract against damage induced by hydrogen peroxide in cultured rat cortical neurons. Korean J of medicinal crop science 2007;15(2):105-11.
|
29 |
Kim HS. Effects of the Korean mistletoe hot-water extract on the lipid components and blood pressure level in spontaneously hypertensive rats. Korean J of Pharmacognosy 2006;37(3):169-76.
|
30 |
Seo JH, Choi YH, Kim JS, Kim SK, Choi SU, Kim YS, et al. Active principles of the methanol extract of Korean mistletoe responsible for the inhibitory effect on the proliferation of human tumor cell lines. Korean J of Pharmacognosy 2004;35(2):134-8.
|
31 |
Enukidze MG, Machavariani MG, Intskirveli NA, Bezhitashvili ND, Sanikidze TV. Cell death in Jurkat cells induced by oxygen/nitrogen stress. Georgian Med News 2009;167:109-13.
|
32 |
Singh S, Gupta AK. Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies. Cancer Chemother Pharmacol 2011;67:1211-24.
DOI
|
33 |
Kato S, Esumi H, Hirano A, Kato M, Asayama K, Ohama E. Immunohistochemical expression of inducible nitric oxide synthase(iNOS) in human brain tumors: relationships of iNOS to superoxide dismutase(SOD) proteins(SOD1 and SOD2), Ki-67 antigen(MIB-1) and p53 protein. Acta Neuropathol 2003;105(4):333-40.
|
34 |
Agudelo-Garcia PA, De Jesus JK, Williams SP, Nowicki MO, Chiocca EA, Liyanarachchi S, et al. Glioma cell migration on three-dimensional nanofiber scaffolds is regulated by substrate topography and abolished by inhibition of STAT3 signaling. Neoplasia 2011;13(9):831-40.
|
35 |
Lamszus K, Kunkel P, Westphal M. Invasion as limitation to anti-angiogenic glioma therapy. Acta Neurochir Suppl 2003;88:169-77.
|
36 |
Deininger MH, Weller M, Streffer J, Mittelbronn M, Meyermann R. Patterns of cyclooxygenase-1 and -2 expression in human gliomas in vivo. Acta Neuropathol 1999;98(3):240-4.
DOI
ScienceOn
|
37 |
Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: a physiologic messenger. Ann Intern Med 1994;120:227-37.
DOI
ScienceOn
|
38 |
Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci 1995;92:7162-6.
DOI
ScienceOn
|
39 |
Mukhopadhyay P, Rajesh M, Batkai S, Kashiwaya Y, Hasko G, Liaudet L, et al. Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin -induced cell death in vivo and in vitro. Am J Physiol Heart Circ Physiol 2009;296:466-83.
|
40 |
Pratheeshkumar P, Kuttan G. Nomilin inhibits tumor-specific angiogenesis by downregulating VEGF, NO and proinflammatory cytokine profile and also by inhibiting the activation of MMP-2 and MMP-9. Eur J Pharmacol 2011;668:450-8.
DOI
ScienceOn
|
41 |
Kostourou V, Cartwright JE, Johnstone AP, Boult JK, Cullis ER, Whitley G, et al. The role of tumour-derived iNOS in tumour progression and angiogenesis. Br J Cancer 2011;104:83-90.
DOI
ScienceOn
|
42 |
Lin WL, Liang WH, Lee YJ, Chuang SK, Tseng TH. Antitumor progression potential of caffeic acid phenethyl ester involving p75(NTR) in C6 glioma cells. Chem Biol Interact 2010;188:607-15.
DOI
ScienceOn
|
43 |
Liu SG, Wang BS, Jiang YY, Zhang TT, Shi ZZ, Yang Y, et al. Atypical protein kinase Ci (PKCi) promotes metastasis of esophageal squamous cell carcinoma by enhancing resistance to Anoikis via PKCi-SKP2-AKT pathway. Mol Cancer Res 2011;9:390-402.
DOI
ScienceOn
|
44 |
Wang J, Wu J, Hong J, Chen R, Xu K, Niu W, et al. PKC promotes the migration of colon cancer cells by regulating the internalization and recycling of integrin . Cancer Lett 2011;311:38-47.
DOI
ScienceOn
|
45 |
Hu JG, Wang XF, Zhou JS, Wang FC., Li XW, Lu HZ. Activation of PKC-alpha is required for migration of C6 glioma cells. Acta Neurobiol Exp 2010;70:239-45.
|
46 |
Lee KG, Cho HJ, Bae YS, Park KK, Choe JY, Chung IK, et al. Bee venom suppresses LPS -mediated NO/iNOS induction through inhibition of PKC-alpha expression. J Ethnopharmacol 2009;123:15-21.
DOI
ScienceOn
|
47 |
Lin TH, Kuo HC, Chou FP, Lu FJ. Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide. BMC Cancer 2008;8:58.
DOI
ScienceOn
|
48 |
Wen J, Ribeiro R, Zhang Y. Specific PKC isoforms regulate LPS-stimulated iNOS induction in murine microglial cells. J Neuroinflammation 2011;8:38.
DOI
ScienceOn
|